Intelligent Bio Solutions Inc. (INBS) Total liabilities 2020–2026
Intelligent Bio Solutions Inc. (INBS) total liabilities at each fiscal year-end, per SEC filings.
$6.7MFY2026 · since FY2020: $7.7M → $6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $6.7M | +22.4% |
| FY2025 | $5.4M | -2.9% |
| FY2024 | $5.6M | -16.1% |
| FY2023 | $6.7M | +14.8% |
| FY2022 | $5.8M | -15.3% |
| FY2021 | $6.9M | -10.9% |
| FY2020 | $7.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More INBS financial trends
INBS RevenueINBS Net incomeINBS Net marginINBS Gross profitINBS Gross marginINBS Operating incomeINBS Operating marginINBS Operating cash flowINBS Free cash flowINBS Capital expendituresINBS Return on equityINBS Stock buybacksINBS Dividends paidINBS Total assetsINBS Shareholders’ equityINBS overview →